Heart Failure and Reduced Ejection Fraction. N Engl J Med. 2019 Nov 21;381(21):1995-2008. \[[PubMed: 31535829](https://pubmed.ncbi.nlm.nih.gov/31535829)\] 43. Heerspink HJL, Stefánsson BV, Correa-Rotter R, Chertow GM, Greene T, Hou FF, Mann JFE, McMurray JJV, Lindberg M, Rossing P, Sjöström CD, Toto RD, Langkilde AM, Wheeler DC., DAPA-CKD Trial Committees and Investigators. Dapagliflozin in Patients with Chronic Kidney Disease. N Engl J Med. 2020 Oct 08;383(15):1436-1446. \[[PubMed: 32970396](https://pubmed.ncbi.nlm.nih.gov/32970396)\] **Disclosure:** Michael Plewa declares no relevant financial relationships with ineligible companies. **Disclosure:** Michael Bryant declares no relevant financial relationships with ineligible companies. **Disclosure:** Robin King-Thiele declares no relevant financial relationships with ineligible companies.